News

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
While Rosie O’Donnell, 63, made a name for herself as a Broadway star and host of the Emmy-winning talk show The Rosie ...
For weight loss, Mounjaro may be prescribed off-label for those with a body mass index (BMI) of 30 or more or 27 or more with at least one weight-related condition, such as high blood pressure ...
No, Mounjaro for weight loss is not approved by the US Food and Drug Administration. However, a drug called Zepbound, which has the same active drug tirzepatide as Mounjaro, is FDA approved for ...
Mounjaro patients were also 2.6 times more likely to achieve 10% weight loss and 1.8 times more likely to lose 5% of their weight, according to Truveta, which was earlier reported on by CNBC.
Diabetes drug Mounjaro helped people lose 16% of weight, study finds Two trials have now found tirzepatide, sold under the brand name Mounjaro as a diabetes treatment, to be effective for weight loss.
Eli Lilly, Mounjaro’s manufacturer, also assessed the drug’s effects on weight loss in the SURMOUNT-1 trial, whose results made a splash at the American Diabetes Association meeting in June 2022.
While Mounjaro is a dual GIP/GLP-1 agonist, Ozempic and Wegovy are both GLP-1 agonists, known chemically as semaglutide, that are currently approved to treat Type 2 diabetes and weight loss ...